Blepharitis

What is Blepharitis

Blepharitis is a chronic inflammation of the eyelid margins. It is one of the most common eyelid conditions seen by eye physicians and oculoplastic surgeons, affecting patients of all ages. Although rarely vision-threatening in its early stages, untreated blepharitis causes progressive discomfort, contributes to dry eye disease, and can lead to corneal damage and eyelid structural changes over time.

Types of Blepharitis

Blepharitis is classified by anatomical location and underlying cause:

Symptoms

• Burning, stinging, or itching of the eyelids — typically worse in the morning
• Red, irritated eyelid margins with visible crusting or scaling at the lash bases
• Eyelids stuck together on waking
• Fluctuating blurred vision from unstable tear film (blinks transiently clear vision)
• Gritty or foreign body sensation
• Mild light sensitivity (more common with corneal involvement or associated dry eye)
• Recurrent chalazia (blocked meibomian gland cysts)
• Lash loss (madarosis) in severe, long-standing cases

Clinical Findings

Slit lamp examination reveals distinct features depending on type:

• Anterior (staph): Collarettes — hard, brittle scales adherent to lashes near follicles. Lash thinning or misdirection (trichiasis). Marginal corneal infiltrates in severe cases.
• Anterior (seborrheic): Soft, greasy flakes on lashes without underlying ulceration. Less follicular involvement than staphylococcal.
• Demodex: Cylindrical sleeves — translucent sheaths surrounding the base of lashes. High-magnification or epilated lash examination shows mites.
• Posterior (MGD): Plugged or capped meibomian orifices. Inspissated (thickened, toothpaste-like) or absent meibomian secretion. Vascular engorgement and notching of the lid margin. Tear break-up time typically shortened.

Meibography (infrared imaging) reveals gland dropout in chronic MGD — a sign of glandular atrophy that is generally irreversible in advanced disease.

Treatment

Blepharitis is a chronic condition requiring long-term management. No single treatment is curative, but consistent hygiene and appropriate therapy significantly reduce inflammation and symptoms.

Eyelid Hygiene

The cornerstone of blepharitis management. Removes debris, unclogs meibomian orifices, and reduces bacterial load:

• Warm compresses: Applied to closed lids for 5–10 minutes to melt inspissated meibum. A warm, moist cloth or a dedicated eyelid warming mask (e.g., the OCuSOFT Dry Eye Mask or a Bruder mask) is used. Essential for posterior blepharitis and MGD.
• Lid massage: After warming, gentle rolling pressure along the lid margin expresses liquefied meibum from gland orifices.
• Lid scrubs: Commercial eyelid cleansers (now preferred over diluted baby shampoo, which may irritate the ocular surface) (OCuSOFT, Systane, Cliradex) clean lash debris and reduce bacterial colonization. Applied with a cotton tip or pad to the eyelid margin in a scrubbing motion.

Antibiotic Therapy

• Topical antibiotics: Azithromycin ophthalmic solution or erythromycin ointment applied to the eyelid margin reduces bacterial colonization and inflammation. Azithromycin (AzaSite) has anti-inflammatory properties in addition to its antibiotic effect.
• Oral doxycycline: Acts on the meibomian glands through an anti-inflammatory effect (matrix-metalloproteinase inhibition) independent of its antibacterial action, so a sub-antimicrobial dose — 20 mg twice daily, or 40 mg modified-release (Oracea) — is often preferred; many oculoplastic surgeons use 20 mg for MGD and ocular rosacea to gain the anti-inflammatory benefit while minimizing antibiotic-resistance pressure, with a conventional 50–100 mg daily course as an alternative. A first-line systemic therapy (after lid hygiene) for moderate-to-severe posterior blepharitis and MGD. Typical course: 1–3 months, sometimes longer in rosacea-associated blepharitis. Side effects: photosensitivity, GI upset. Contraindicated in pregnancy, breastfeeding, and children under 8 (tooth/bone effects); use sun protection.
• Oral tetracycline, minocycline: Alternatives to doxycycline with similar mechanism.

Demodex-Specific Treatment

For Demodex blepharitis, eyelid tea tree oil (terpinen-4-ol) scrubs or weekly in-office treatments are effective. XDEMVY (lotilaner ophthalmic solution 0.25%) — FDA-approved specifically for Demodex blepharitis — is applied twice daily for 6 weeks and has demonstrated significant reduction in mite counts and collarettes in clinical trials.

In-Office Procedures

• BlephEx: Mechanical debridement of the eyelid margin using a rotating micro-sponge device. Removes biofilm, collarettes, and debris; unclogs meibomian orifices.
• Intense Pulsed Light (IPL): Treats posterior blepharitis by applying pulsed light to the periocular skin, heating meibomian glands, reducing Demodex populations, and reducing telangiectasias. Multiple sessions (3–4) spaced 3–4 weeks apart.
• Thermal pulsation (LipiFlow): Applies simultaneous heat to the inner eyelid surface and pulsatile pressure to express inspissated meibomian gland content. A single 12-minute treatment per eye.
• Manual expression: Meibomian gland expression in clinic using paddles or forceps after lid warming — directly clears obstructed glands.

Complications of Untreated Blepharitis

• Chalazion: Chronic blockage of meibomian glands progresses to a lipogranulomatous cyst (chalazion). Recurrent chalazia are often a sign of underlying posterior blepharitis or MGD.
• Meibomian gland dropout: Progressive glandular atrophy visible on meibography — permanent loss of gland tissue leading to irreversible dry eye.
• Marginal keratitis: Peripheral corneal infiltrates from immune reaction to staphylococcal antigens — may require a short course of topical steroids under ophthalmologist supervision, with intraocular pressure monitoring and after excluding infectious (including herpetic) causes.
• Corneal neovascularization and pannus: In severe, longstanding cases.
• Trichiasis and madarosis: Misdirected or lost lashes from chronic follicular inflammation.
• Worsening dry eye: Meibomian lipid deficiency accelerates tear evaporation and perpetuates the blepharitis-dry eye cycle.

At-Home Lid Hygiene

Blepharitis is usually a chronic condition managed rather than cured, and consistent lid hygiene is the foundation of every treatment plan:

• Warm compresses for several minutes to soften oils and loosen crusts.
• Lid margin cleaning with a gentle cleanser or eyelid wipe to remove debris and bacteria.
• Consistency: daily routine, continued even when symptoms improve, because stopping usually brings symptoms back.
• Omega-3 intake and blink hygiene support the meibomian glands.

When to See a Doctor

See an eye doctor if you have persistent redness, pain, light sensitivity, blurred vision, eyelash loss, or a recurring lump — these can signal complications or, rarely, a masquerading tumor. Blepharitis also drives and worsens dry eye and can trigger a chalazion.

Ongoing Medical Management

When hygiene alone is not enough, treatment is tailored to the type: topical or short-course antibiotics, low-dose oral doxycycline for posterior blepharitis and ocular rosacea, in-office procedures for Demodex, and IPL or gland-expression for meibomian dysfunction. Realistic expectations matter: the goal is control and comfort, not a one-time cure.

Continue Reading — Complete Blepharitis Guide

• Demodex Blepharitis
• Meibomian Gland Dysfunction
• Ocular Rosacea
• Dry Eye
• Floppy Eyelid Syndrome